Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of combination chemotherapy with or without
trastuzumab in treating women who have metastatic breast cancer. Drugs used in chemotherapy
use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal
antibodies such as trastuzumab can locate tumor cells and either kill them or deliver
tumor-killing substances to them without harming normal cells.